Generic and Branded Enoxaparin Bioequivalence: A Clinical and Experimental Study
نویسنده
چکیده
Hamdi Boubaker MD1,8, Mohamed Habib Grissa MD1,8, Mouna Sassi MD2,8, Taher Chakroun MD3, Kaouthar Beltaief MD1,8, Mohsen Hassine MD4,8, Grigoris T Gerotziafas MD5, Rabie Razgallah MD6, Wahid Bouida MD1,8, Riadh Boukef MD7,8, Ismail Elalamy MD5 and Semir Nouira MD1,8* 1Emergency Department, Fattouma Bourguiba University Hospital, Monasitr 5000, Tunisia 2Biological Laboratory, Maternity and Neonatal Medicine Center, Monastir 5000, Tunisia 3Regional Blood Transfusion Center, Farhat Hached University Hospital, Sousse 4004, Tunisia 4Hematology Department, Fattouma Bourguiba University Hospital, Monasitr 5000, Tunisia 5Biological Hematology Department, Hospital Tenon, Paris, France 6Research Department, Medis Laboratory Tunisia 7Emergency Department, Sahloul University Hospital, Sousse 4011, Tunisia 8Research Laboratory (LR12SP18), University of Monastir 5000 Tunisia
منابع مشابه
Generic versus branded enoxaparin in prophylaxis and treatment of vein thrombosis.
OBJECTIVES to compare the biological efficacy of generic enoxaparin (HeptronTM) versus branded Sanofi-Aventis enoxaparin for prophylaxis and treatment of lower-extremity deep venous thrombosis (DVT) in a prospective, randomized, open-label study. METHODS patients with diagnosed lower-extremity DVT (therapeutic branch, n=57) and patients requiring venous thromboembolism (VTE) prophylaxis after...
متن کاملEvaluation of Immunostimulatory Potential of Branded and US-Generic Enoxaparins in an In Vitro Human Immune System Model
Low-molecular-weight heparins (LMWHs) have several positive therapeutic effects and can also form immunostimulatory complexes with plasma proteins, such as platelet factor 4 (PF4). We compared the innate response and functional profiles of branded and US-generic enoxaparins from 2 manufacturers in either native or PF4-bound forms in an in vitro model of human immunity. In an analysis of 2 produ...
متن کاملBioequivalence of generic and branded amoxicillin capsules in healthy human volunteers
CONTEXT The Medical Council of India urges doctors to prescribe generic drugs as far as possible. The Indian Medical Association had responded earlier saying that it requires guarantees on the quality of generic forms of drugs. Although no published scientific reports are available on the issue of therapeutic inequivalence, unconfirmed clinician accounts and newspaper reports of therapeutic ine...
متن کاملNomenclature and Traceability Debate for Biosimilars: Small-Molecule Surrogates Lend Support for Distinguishable Nonproprietary Names
INTRODUCTION The purpose of the present study was to investigate the traceability of adverse events (AEs) for branded and generic drugs with identical nonproprietary names and to consider potential implications for the traceability of AEs for branded and biosimilar biologics. METHODS Adverse event reports in the Food and Drug Administration AE Reporting System (FAERS) were compared with those...
متن کاملComparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers
PURPOSE The primary aim of the present study was to assess the pharmacokinetic bioequivalence between a generic formulation of meloxicam 15 mg tablets (Meloxicam Hexal) and its respective brand product (Mobic), in order to verify whether the generic product conforms to the regulatory standards of bioequivalence in the postmarketing setting. As a secondary exploratory aim, the pharmacodynamic ef...
متن کامل